Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2025

payment-methods
Secure Payment Methods

The SPECT Radiopharmaceuticals market research report from Marketresearchpro consolidates the most important industry information while highlighting essential and valuable data regarding the status quo and trajectory of the SPECT Radiopharmaceuticals industry with forecasts through next 5 years.

A management summary, key facts & figures, SWOT analysis and chief executive quotes on the latest developments in SPECT Radiopharmaceuticals industry provide a substantial introduction. The report additionally provides quantitative information regarding SPECT Radiopharmaceuticals industry financial numbers, selected key players and company details, as well as employee and salary data.

In the coming years, SPECT Radiopharmaceuticals market will continue to focus their efforts on product innovation in order to attract new consumers and keep existing consumers loyal to specific brands.

Below is the majority of the content covered in this report

  • SPECT Radiopharmaceuticals Product details, including pictures and technical specifications
  • SPECT Radiopharmaceuticals manufacturers, distributors and channels
  • Major players present in the SPECT Radiopharmaceuticals
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

This report covers a strategic profiling of the following key players in the SPECT Radiopharmaceuticals market

  • Cardinal Health Inc. (U.S.)
  • Mallinckrodt plc (Ireland)
  • GE Healthcare (U.K.)
  • Lantheus Medical Imaging
  • Inc. (U.S.)
  • Bayer Healthcare (Germany)
  • Bracco Imaging S.p.A (Italy)
  • Eczacibasi-Monrol Nuclear Products (Turkey)
  • Nordion
  • Inc. (Canada)
  • Advanced Accelerator Applications S.A. (France)
  • IBA Molecular Imaging (Belgium)

The report covers the information pertaining to following geographies

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

Additionally, the market is segmented by the following sectors

  • Tc-99
  • Tl-201
  • Ga-67
  • I-123
  • Others

Please contact us if you are looking for any other possible breakdown across the products.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Diagnostics
  • Therapeutics

In summary, the report serves to study and analyse the SPECT Radiopharmaceuticals size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of SPECT Radiopharmaceuticals, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Study Coverage
    • 1.1 SPECT Radiopharmaceuticals Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type
      • 1.4.2 Tc-99
      • 1.4.3 Tl-201
      • 1.4.4 Ga-67
      • 1.4.5 I-123
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application
      • 1.5.2 Diagnostics
      • 1.5.3 Therapeutics
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Executive Summary
    • 2.1 Global SPECT Radiopharmaceuticals Market Size
      • 2.1.1 Global SPECT Radiopharmaceuticals Revenue 2016-2025
      • 2.1.2 Global SPECT Radiopharmaceuticals Sales 2016-2025
    • 2.2 SPECT Radiopharmaceuticals Growth Rate by Regions
      • 2.2.1 Global SPECT Radiopharmaceuticals Sales by Regions
      • 2.2.2 Global SPECT Radiopharmaceuticals Revenue by Regions
  • 3 Breakdown Data by Manufacturers
    • 3.1 SPECT Radiopharmaceuticals Sales by Manufacturers
      • 3.1.1 SPECT Radiopharmaceuticals Sales by Manufacturers
      • 3.1.2 SPECT Radiopharmaceuticals Sales Market Share by Manufacturers
      • 3.1.3 Global SPECT Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
    • 3.2 SPECT Radiopharmaceuticals Revenue by Manufacturers
      • 3.2.1 SPECT Radiopharmaceuticals Revenue by Manufacturers (2016-2018)
      • 3.2.2 SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
    • 3.3 SPECT Radiopharmaceuticals Price by Manufacturers
    • 3.4 SPECT Radiopharmaceuticals Manufacturing Base Distribution, Product Types
      • 3.4.1 SPECT Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers SPECT Radiopharmaceuticals Product Category
      • 3.4.3 Date of International Manufacturers Enter into SPECT Radiopharmaceuticals Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Type
    • 4.1 Global SPECT Radiopharmaceuticals Sales by Type
    • 4.2 Global SPECT Radiopharmaceuticals Revenue by Type
    • 4.3 SPECT Radiopharmaceuticals Price by Type
  • 5 Breakdown Data by Application
    • 5.1 Overview
    • 5.2 Global SPECT Radiopharmaceuticals Breakdown Data by Application
  • 6 North America
    • 6.1 North America SPECT Radiopharmaceuticals by Countries
      • 6.1.1 North America SPECT Radiopharmaceuticals Sales by Countries
      • 6.1.2 North America SPECT Radiopharmaceuticals Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America SPECT Radiopharmaceuticals by Type
    • 6.3 North America SPECT Radiopharmaceuticals by Application
    • 6.4 North America SPECT Radiopharmaceuticals by Company
  • 7 Europe
    • 7.1 Europe SPECT Radiopharmaceuticals by Countries
      • 7.1.1 Europe SPECT Radiopharmaceuticals Sales by Countries
      • 7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe SPECT Radiopharmaceuticals by Type
    • 7.3 Europe SPECT Radiopharmaceuticals by Application
    • 7.4 Europe SPECT Radiopharmaceuticals by Company
  • 8 Asia Pacific
    • 8.1 Asia Pacific SPECT Radiopharmaceuticals by Countries
      • 8.1.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Countries
      • 8.1.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific SPECT Radiopharmaceuticals by Type
    • 8.3 Asia Pacific SPECT Radiopharmaceuticals by Application
    • 8.4 Asia Pacific SPECT Radiopharmaceuticals by Company
  • 9 Central & South America
    • 9.1 Central & South America SPECT Radiopharmaceuticals by Countries
      • 9.1.1 Central & South America SPECT Radiopharmaceuticals Sales by Countries
      • 9.1.2 Central & South America SPECT Radiopharmaceuticals Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America SPECT Radiopharmaceuticals by Type
    • 9.3 Central & South America SPECT Radiopharmaceuticals by Application
    • 9.4 Central & South America SPECT Radiopharmaceuticals by Company
  • 10 Middle East and Africa
    • 10.1 Middle East and Africa SPECT Radiopharmaceuticals by Countries
      • 10.1.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Countries
      • 10.1.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa SPECT Radiopharmaceuticals by Type
    • 10.3 Middle East and Africa SPECT Radiopharmaceuticals by Application
    • 10.4 Middle East and Africa SPECT Radiopharmaceuticals by Company
  • 11 Company Profiles
    • 11.1 Cardinal Health Inc. (U.S.)
      • 11.1.1 Cardinal Health Inc. (U.S.) Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.1.4 SPECT Radiopharmaceuticals Product Description
      • 11.1.5 Recent Development
    • 11.2 Mallinckrodt plc (Ireland)
      • 11.2.1 Mallinckrodt plc (Ireland) Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.2.4 SPECT Radiopharmaceuticals Product Description
      • 11.2.5 Recent Development
    • 11.3 GE Healthcare (U.K.)
      • 11.3.1 GE Healthcare (U.K.) Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.3.4 SPECT Radiopharmaceuticals Product Description
      • 11.3.5 Recent Development
    • 11.4 Lantheus Medical Imaging, Inc. (U.S.)
      • 11.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.4.4 SPECT Radiopharmaceuticals Product Description
      • 11.4.5 Recent Development
    • 11.5 Bayer Healthcare (Germany)
      • 11.5.1 Bayer Healthcare (Germany) Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.5.4 SPECT Radiopharmaceuticals Product Description
      • 11.5.5 Recent Development
    • 11.6 Bracco Imaging S.p.A (Italy)
      • 11.6.1 Bracco Imaging S.p.A (Italy) Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.6.4 SPECT Radiopharmaceuticals Product Description
      • 11.6.5 Recent Development
    • 11.7 Eczacibasi-Monrol Nuclear Products (Turkey)
      • 11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.7.4 SPECT Radiopharmaceuticals Product Description
      • 11.7.5 Recent Development
    • 11.8 Nordion, Inc. (Canada)
      • 11.8.1 Nordion, Inc. (Canada) Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.8.4 SPECT Radiopharmaceuticals Product Description
      • 11.8.5 Recent Development
    • 11.9 Advanced Accelerator Applications S.A. (France)
      • 11.9.1 Advanced Accelerator Applications S.A. (France) Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.9.4 SPECT Radiopharmaceuticals Product Description
      • 11.9.5 Recent Development
    • 11.10 IBA Molecular Imaging (Belgium)
      • 11.10.1 IBA Molecular Imaging (Belgium) Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of SPECT Radiopharmaceuticals
      • 11.10.4 SPECT Radiopharmaceuticals Product Description
      • 11.10.5 Recent Development
  • 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators
  • 13 Value Chain and Sales Channels Analysis
    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key SPECT Radiopharmaceuticals Raw Material
      • 13.1.2 SPECT Radiopharmaceuticals Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors
  • 14 Research Findings and Conclusion
  • 15 Appendix
    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
        • 15.1.1.1 Research Programs/Design
        • 15.1.1.2 Market Size Estimation
        • 15.1.1.3 Market Breakdown and Data Triangulation
      • 15.1.2 Data Source
        • 15.1.2.1 Secondary Sources
        • 15.1.2.2 Primary Sources
    • 15.2 Author Details
    • 15.3 Disclaimer

Request a FREE Sample


PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers

Request a FREE Sample